Russell Jacob Page Insider Profile

4 Followers
Russell Jacob Page, Director at Sonnet BioTherapeutics Holdings, holds 26.97K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN), holds 0.00 shares in Diamond Hill Financial Trends Fund (Ticker: DHFT).
tipranks
Russell Jacob Page

Russell Jacob Page
Sonnet BioTherapeutics Holdings (SONN)
Director

Not Ranked
Russell Jacob Page has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$23K
100.00%
A breakdown of Russell Jacob Page's holdings

Insider Roles

Sonnet BioTherapeutics Holdings
(SONN)
Director
Roles that Russell Jacob Page holds in companies

Most Profitable Insider Trade

Stock:
Sonnet BioTherapeutics Holdings
(SONN)
Rating:Informative Buy
Date:Jul 30, 2015 - Jul 30, 2016
Return:-82.90%
The most profitable trade made by Russell Jacob Page

Russell Jacob Page's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sonnet BioTherapeutics Holdings
May 14, 2019
Director
Uninformative Buy
$23.41K
DHFT
Diamond Hill Financial Trends Fund
Mar 26, 2013
Uninformative Sell
73.53K
List of latest transactions for each holding click on a transaction to see Russell Jacob Page's performance on stock

Russell Jacob Page insider profile FAQ

What is the percentage of profitable transactions made by Russell Jacob Page?
The percentage of profitable transactions made by Russell Jacob Page is ―.
    What is the average return per transaction made by Russell Jacob Page?
    The average return per transaction made by Russell Jacob Page is ―.
      What stocks does Russell Jacob Page hold?
      Russell Jacob Page holds: SONN, DHFT stocks.
        What was Russell Jacob Page’s latest transaction?
        Russell Jacob Page latest transaction was an Uninformative Buy of ―.
          What was Russell Jacob Page's most profitable transaction?
          Russell Jacob Page’s most profitable transaction was an Informative Buy of SONN stock on July 30, 2015. The return on the trade was -82.90%.
            What is Russell Jacob Page's role in Sonnet BioTherapeutics Holdings?
            Russell Jacob Page's role in Sonnet BioTherapeutics Holdings is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.